Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

University of Toronto

$25,000.00

Development of Rapid and High-Throughput Genetic Fingerprinting Assay for the Identification of Specific Intestinal Microbes

FY 2017-18

Summary
There is an increasing awareness that our microbiota plays an important role in a variety of pathologicaldisorders including obesity, diabetes, Parkinson's disease, multiple sclerosis, and colorectal cancer.Personalized medicine will evolve to include assays for the presence or absence of particular microbes incomplex samples (e.g. stool). Most microbes are uncultivable and current genomic sequencing techniques arehigh resolution but slow and expensive. There will be an increasing need for targeted, inexpensive, and rapidculture-free methods to identify particular microbes from a variety of patient and environmental samples.MassArray technology is used to identify genetic polymorphisms for genetic testing. MassArray involvesthe selective PCR amplification of as many as 40 different loci (multiplex PCR), where specific variants(mutations) are subsequently identified by mass spectrometry (MALDI-TOF). Arctic Diagnostics Inc.(ArcticDx, Toronto) has extensive experience in the use of MassArray, performing ~100,000 genetic tests onpatients over the past 5 years to identify risk alleles for macular degeneration, cystic fibrosis, and gestationaldiabetes. Given recent evidence that microbiota play a role in each of these diseases, ArcticDx is motivated toexpand the application of their MassArray to identify specific microbial ""fingerprints"" in patient samples.Toward this end Arctic wishes to establish a collaboration with Dr. William Navarre (University ofToronto), a microbiologist who has spent the past three years developing tools to culture and analyzemicrobiota samples from both humans and mice. We have developed a clear and technically feasible plan todetermine if MassArray technology can be employed to simultaneously identify the presence or absence of upto 20 specific microbes from complex (mouse stool) samples. This will involve the development of multiplexprimer sets specific to individual microbial species and troubleshooting the PCR, MALDI-TOF, andcomputational parameters necessary to achieve acceptable levels of specificity and selectivity.
Program
Engage Grants Program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
522743-2017
Name nom
Navarre, William
Department département
Molecular Genetics
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
515
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Instrumentation technology
Area of application fr
Technologie de l'instrumentation
Research subject code
5200
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Microbiology
Research subject fr
Microbiologie
Partie
1
Nb partie
1
Application title
Development of Rapid and High-Throughput Genetic Fingerprinting Assay for the Identification of Specific Intestinal Microbes
Keyword
NSERC
Application summary
There is an increasing awareness that our microbiota plays an important role in a variety of pathologicaldisorders including obesity, diabetes, Parkinson's disease, multiple sclerosis, and colorectal cancer.Personalized medicine will evolve to include assays for the presence or absence of particular microbes incomplex samples (e.g. stool). Most microbes are uncultivable and current genomic sequencing techniques arehigh resolution but slow and expensive. There will be an increasing need for targeted, inexpensive, and rapidculture-free methods to identify particular microbes from a variety of patient and environmental samples.MassArray technology is used to identify genetic polymorphisms for genetic testing. MassArray involvesthe selective PCR amplification of as many as 40 different loci (multiplex PCR), where specific variants(mutations) are subsequently identified by mass spectrometry (MALDI-TOF). Arctic Diagnostics Inc.(ArcticDx, Toronto) has extensive experience in the use of MassArray, performing ~100,000 genetic tests onpatients over the past 5 years to identify risk alleles for macular degeneration, cystic fibrosis, and gestationaldiabetes. Given recent evidence that microbiota play a role in each of these diseases, ArcticDx is motivated toexpand the application of their MassArray to identify specific microbial ""fingerprints"" in patient samples.Toward this end Arctic wishes to establish a collaboration with Dr. William Navarre (University ofToronto), a microbiologist who has spent the past three years developing tools to culture and analyzemicrobiota samples from both humans and mice. We have developed a clear and technically feasible plan todetermine if MassArray technology can be employed to simultaneously identify the presence or absence of upto 20 specific microbes from complex (mouse stool) samples. This will involve the development of multiplexprimer sets specific to individual microbial species and troubleshooting the PCR, MALDI-TOF, andcomputational parameters necessary to achieve acceptable levels of specificity and selectivity.